A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorder. [PDF]
Int J NeuropsychopharmacolMoriguchi S +10 more
europepmc +1 more source
Explainable counterfactual reasoning in depression medication selection at multi-levels (personalized and population). [PDF]
BMC Med Inform Decis MakQin X +7 more
europepmc +1 more source
Oxaliplatin-induced peripheral neuropathy: from pathogenesis to treatment. [PDF]
Support Care CancerZhou HY +5 more
europepmc +1 more source
Case Report: Complexities in the Management of Glossopharyngeal Neuralgia: Lessons from a Refractory Case. [PDF]
Clin Med Insights Case RepMaksymowicz R +4 more
europepmc +1 more source
Potent LeuBAT inhibitors designed in silico as next-generation duloxetine analogs for enhanced major depressive disorder treatment. [PDF]
Sci RepYoosefian M +3 more
europepmc +1 more source
Duloxetine and pregabalin: High-dose monotherapy or their combination?-Study protocol for a randomized trial in patients with postoperative pain after total knee arthroplasty based on the classification of central sensitization inventory scores. [PDF]
PLoS OneWu H, Yao S, Huang Y, Xu C, Ma J.
europepmc +1 more source
Clinical benefits and considerations of dextromethorphan and bupropion administered separately for managing depression: A case report. [PDF]
Ment Health ClinHaghparast P, Olotu B, Yuan C.
europepmc +1 more source
A Pilot Study: Comparative Effects of Green Tea Extract and Duloxetine on Oxaliplatin-Induced Allodynia in a Murine Model. [PDF]
MetabolitesDaniel M +6 more
europepmc +1 more source
Theory of planned behavior constructs are associated with willingness to engage in clinical trial interventions for chronic low back pain: A cross-sectional survey study. [PDF]
J Clin Transl SciSteeby C +4 more
europepmc +1 more source